Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
83 hedge funds and large institutions have $206M invested in Applied Therapeutics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 4 closing their positions.
5,082% more call options, than puts
Call options by funds: $26.4M | Put options by funds: $510K
700% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 4
145% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 11
92% more capital invested
Capital invested by funds: $107M → $206M (+$98.8M)
51% more funds holding
Funds holding: 55 → 83 (+28)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
11.49% more ownership
Funds ownership: 68.08% → 79.57% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$10.2M |
| 2 |
Janus Henderson Group
London,
|
+$5.35M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.48M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$4.13M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$8.47M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.02M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$2.31M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.82M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.82M |
APLT Hedge Fund Activity: Q4 2023 in Review
83 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q4 2023, worth a combined $206M — up 92% from $107M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new APLT positions and 4 closed out — a net gain of 28 holders — while 27 added to existing stakes and 11 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $10.2M. The largest seller was Armistice Capital, exiting entirely with an estimated $8.47M sold.
- 83 institutional investors held Applied Therapeutics (APLT) as of Q4 2023, up from 55 in Q3 2023.
- Funds reported $206M of Applied Therapeutics stock for Q4 2023, up 92% quarter-over-quarter.
- 32 funds opened new Applied Therapeutics positions in Q4 2023 and 4 closed out, a net change of +28 holders.
- The largest Applied Therapeutics buyer in Q4 2023 was Perceptive Advisors, an estimated $10.2M added.
- The largest Applied Therapeutics seller in Q4 2023 was Armistice Capital, an estimated $8.47M sold.
Based on aggregated 13F filings for Q4 2023.